Carbamazepine: Risk Groups

Pregnant women:
Teratogenic effects are suspected (e.g. cleft spine), but other antiepileptic agents can be even riskier. Do not withdraw antiepileptic agents unpremeditatedly! The plasma levels normally decrease during pregnancy.

Nursing mothers:
Carbamazepine and carbamazepine epoxide appear in small quantities in breast milk. Breast-feeding is permitted.

Children:
Children metabolize carbamazepine quicker: half-life is 6 to 12 hours (for long-term treatment). Initial dose: twice daily 5 to 8 mg/kg; increase carefully.

Elderly people:
Administer a small initial dose (100 mg twice a day).

Renal failure:
Reduce regular dose by 25% when there is advanced insufficiency.

Liver insufficiency:
Carefully monitor side-effects. Plasma level may have to be determined.

Table of Contents | Indications | Pharmacology | Adverse Reactions & Interactions | Contraindications & Cautions | References